Intellectual Property as ABL Collateral: How Patents, Trademarks, and License Royalties Get Underwritten

The Capital Stack Question Asset-Light Borrowers Keep Asking

The call usually starts the same way. A founder, a CFO, or a sponsor on the other end of the line says some version of: we have valuable IP, we have licensing revenue, but our balance sheet does not have the receivables or inventory a traditional ABL lender wants. Can we borrow against the IP itself?

The honest answer is yes, but not from most banks. IP-backed lending is a specialty discipline with a narrow lender universe, conservative advance rates, and credit committees that treat intangible assets very differently from accounts receivable or finished goods. Done right, it unlocks meaningful liquidity for borrowers who would otherwise be told to raise equity. Done wrong, it produces a non-closeable deal package and a wasted six months.

This is the playbook for getting an IP-collateralized facility underwritten and closed. It is built on the same disciplines covered in Asset Based Lending Disciplines, the textbook that has trained more than 5,000 ABL professionals at GE Capital, JP Morgan Chase, Lloyds, and Barclays, applied to the specific mechanics of intangible collateral.

What Counts as IP Collateral

Lenders divide intellectual property into four categories, each with very different collateral quality:

Patents

The strongest IP collateral is a granted patent with broad claims, ten or more years of remaining life, a documented licensing history with third-party royalty income, and registrations in major markets (US, EU, Japan, China). Single-patent portfolios with narrow claims and no licensing revenue are essentially uncollateralizable. Lenders look for portfolios of 50 or more related patents in a defined technology cluster, ideally including standard-essential patents under FRAND commitments. Survival of validity challenges is a meaningful credit positive.

Trademarks

Trademarks with established market recognition, attributable revenue, and active licensing or franchising programs underwrite well. The indefinite life of a trademark (with renewal) is an underwriting advantage versus patents. The credit case rests on revenue traceability: can the lender point to specific product lines or franchise fees that exist only because the brand exists? If yes, the trademark is real collateral. If the brand contribution to revenue is diffuse or co-branded with other marks, the haircut grows.

Copyrights and Content Libraries

Useful when the asset is a content library with predictable subscription, streaming, or licensing revenue. Music catalogs, software libraries, film and television rights, and educational content with recurring royalty streams all qualify. The valuation discipline is the same as for trademarks: revenue must be specifically attributable to the copyrighted asset.

License Royalty Streams

The cleanest IP-backed structure is often not a direct lien on the IP itself but a securitization of the cash flows it generates. If a borrower has a portfolio of license agreements with creditworthy counterparties producing predictable royalty income, those cash flows can be financed at materially better advance rates than the underlying IP. This is functionally a receivables financing layered onto an intangible asset.

The Four Underwriting Dimensions

Every IP lender — whether a specialty fund, a hedge fund debt desk, or a commercial bank with a dedicated IP practice — evaluates the collateral against four dimensions. Borrowers who walk in unable to demonstrate strength on all four will not close.

1. Legal Enforceability

Is the IP granted, not merely applied for? Is it registered in the jurisdictions that matter? Are there pending oppositions, invalidity proceedings, or co-ownership disputes? Lenders require a freedom-to-operate analysis and a title chain opinion from outside IP counsel. Pending applications and informal trade secrets do not collateralize. Granted, registered, and unencumbered IP does.

2. Independent Valuation

The borrower's own valuation is worthless to a credit committee. The lender will require an independent appraisal from a recognized IP valuation firm, using the three accepted approaches: income (discounted royalty or relief-from-royalty), market (comparable transactions in secondary markets), and cost (rare for IP, but applied for defensive portfolios). The appraisal must produce both a going-concern value and a distressed liquidation value. The going-concern number drives borrowing base availability. The liquidation number drives the haircut.

3. Revenue Traceability

This is where most deals fall apart. Lenders need to see revenue that exists because of the IP and would disappear without it. A patent that underpins an identifiable product line with attributable margin is real collateral. A patent whose contribution to a unified product offering cannot be isolated will be assigned little value. Borrowers should prepare a revenue attribution memo before approaching lenders, segmenting revenue by IP asset where possible.

4. Liquidation Value and Secondary Market

If the borrower defaults, can the lender recover? IP recovery requires a secondary market — patent assertion entities, competitors, strategic acquirers, or licensing aggregators willing to buy or license the asset. The buyer universe for a software patent is different from the buyer universe for a pharmaceutical trademark. Lenders estimate distressed liquidation at 20 to 40 percent of going-concern value. This is the floor that determines how much credit they will extend.

Advance Rates: What to Expect

IP advance rates are materially lower than tangible asset advances. For context, accounts receivable typically advance at 80 to 90 percent of eligibles, and inventory at 50 to 65 percent of net orderly liquidation value (covered in detail in our piece on ABL appraisals and how NOLV is calculated). IP advance rates run materially below those benchmarks.

The general range:

• 20 to 30 percent of independent going-concern valuation for portfolios that meet basic enforceability and revenue traceability tests
• 30 to 40 percent for strong portfolios with active licensing income, established secondary market depth, and clean title
• 40 to 50 percent only for exceptional cases: standard-essential patent portfolios, blue-chip trademark families, or securitized royalty streams from investment-grade licensees

For comparison, the EUIPO 2026 IP-backed finance report notes that financial institutions typically apply conservative haircuts or outright exclusion of IP from recoverable value in the absence of guarantee schemes. The lenders who actually fund IP collateral have built the underwriting infrastructure to price the risk themselves.

Where IP Fits in the Capital Stack

IP rarely stands alone as primary collateral. More commonly, it functions in three configurations:

Bifurcated Collateral Structure

A senior ABL lender takes a first lien on receivables, inventory, and machinery. A junior IP-focused lender takes a first lien on the IP and a second lien on the tangible assets. The two are governed by an intercreditor agreement that defines priority, payment blockage, and standstill terms. This is one of the most common structures and we have covered the mechanics in detail in our intercreditor agreement guide.

Credit Enhancer Within a Single Facility

The senior lender takes a lien on all assets including IP but assigns only modest value to the IP within the borrowing base. The IP is not the deal — it is incremental availability layered onto a conventional ABL structure. This works when the IP value is meaningful but the tangible collateral can carry most of the credit.

Stretch or FILO Tranche Secured by IP

A first-in-last-out tranche is added to a conventional ABL, with the FILO collateralized partly or wholly by the IP. The FILO bears higher pricing in exchange for the riskier collateral position. We covered this structure in our FILO and overadvance guide — when the stretch capacity comes from intangibles, the structuring discipline is the same but the appraisal work changes entirely.

The Lender Universe

Most commercial banks do not lend against IP as primary collateral. The active lenders fall into several groups:

• Specialty IP-focused funds with dedicated underwriting teams, in-house IP counsel, and relationships with patent assertion entities and licensing aggregators on the recovery side
• Hedge fund debt desks running structured credit strategies that include intangible asset exposure
• Royalty securitization platforms that finance license cash flows rather than the underlying IP
• A small set of commercial banks with mature IP practices — typically large institutions with the credit infrastructure to absorb the additional underwriting cost
• Mezzanine and high-yield lenders using IP as part of an all-asset collateral package alongside subordinated debt

Matching the right deal to the right lender is what separates a closeable transaction from a six-month dead end. The community is small. The lenders who will look at an IP deal know each other, share appraisers, and have well-defined appetites. Going in cold without the relationships is one of the most common reasons deals stall — and one of the patterns we documented in why your ABL deal got declined.

Pre-Closing Preparation

Borrowers who close IP-backed facilities do the work before they approach lenders. The minimum preparation list:

• IP audit — inventory all owned IP, verify registration status and renewal dates across all jurisdictions
• Title chain review — confirm clean ownership, resolve any assignment gaps from acquisitions, hires, or contractor work
• Independent valuation — engage a recognized IP valuation firm three to six months before the financing target date
• Revenue attribution memo — document which revenue streams are attributable to which IP assets, with margin detail where possible
• Freedom-to-operate opinion — confirm no third-party infringement risks that would impair collateral value
• License agreement summary — every license in and out, with counterparty credit profile, royalty terms, term remaining, and any termination triggers

This work runs in parallel with the standard ABL diligence covered in our due diligence checklist. Borrowers who arrive with both packages ready close faster and at better terms.

Execution Discipline

Don Clarke has been packaging and placing asset-based deals for more than four decades, including the more complex structures where intangible assets carry part of the credit. He founded ABLC in 1986 and was inducted into the Secured Finance Network Hall of Fame in 2021 along with the Lifetime Achievement Award. The book he authored — Asset Based Lending Disciplines, the first textbook on the field — is the same framework applied to IP-backed transactions today.

IP-backed financing is a discipline. The deals that close share four characteristics: the borrower prepared properly before going to market, the right lenders were approached for the specific collateral profile, the valuation work was done by an appraiser the lender trusts, and the structure was negotiated with a clear understanding of how the intercreditor mechanics will work if things go wrong.

We do not consult. We execute.